Transparency. Performance. Growth.
Transparency. Performance. Growth.
NovaMed
Key financial highlights
Revenue (FY)
₦145.2bn
EBITDA Margin
18.4%
Capex (FY)
₦22.6bn
Export Markets
12
NovaMed
Corporate governance
NovaMed is committed to sound governance, independent oversight, and transparent reporting aligned with stakeholder expectations.
Corporate Governance
The Audit Committee supports oversight of financial reporting integrity, risk management, and compliance controls.
Stock information
NGX Listing (placeholder): NOVAMED
NOVAMED
Shareholder information
- Dividends (policy overview)
- AGM notices
- Investor updates
Press releases
Press releases, industry updates, health tips, and events from NovaMed.
NovaMed
Investor relations contact
investors@novamedpharma.com
Send a message